How a Miami Life Science Firm Grew from a Son’s Mission to Fight Oral Cancer

How a Miami Life Science Firm Grew from a Son’s Mission to Fight Oral Cancer February 25, 2015 Entrepreneur Matthew H.J. Kim wished his mother’s oral cancer had been caught earlier. He struggled to watch her go through treatments for the disease, including the removal of part of her jawbone. There had to be a

Vigilant Raises $5.5M in Funding

Vigilant Raises $5.5M in Funding February 25, 2015 Vigilant Biosciences has raised $5.5 million in Series B funding. The company intends to use the newly raised funds to get U.S. and European approval for its oral cancer device, the OncAlert oral cancer risk assessment system. The OncAlert system detects specific protein markers known to indicate

Vigilant Biosciences Closes $5.5 Million Series B Round of Funding

Vigilant Biosciences Closes $5.5 Million Series B Round of Funding February 24, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the successful completion of a $5.5 million Series B round of funding, bringing the total amount of

Miami Life Science Startup Stems from Personal Mission to Fight Oral Cancer

Miami Life Science Startup Stems from Personal Mission to Fight Oral Cancer February 24, 2015 Matthew H.J. Kim, a patent attorney by training, was heart-broken by the suffering and aggressive treatment his mother went through with oral cancer. He also saw first-hand the results of what he calls an inadequate standard of care resulting in

Miami Startup Raises $5.5M for Cancer Risk Detection System

Miami Startup Raises $5.5M for Cancer Risk Detection System February 24, 2015 Miami-based Vigilant Biosciences raised $5.5 million to launch its oral cancer risk detection system, the firm announced Tuesday. Investors included White Owl Capital Partners, venVelo and the Florida Institute for the Commercialization of Public Research. The company has raised $7.8 million to date.

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev C